A woman holding a credit card while using a laptop
·
4 Min Read

AMA to Congress: Patients pay painful price for high drug costs

AMA leader tells of a patient who relies on an older drug that rose in price by 400% to about $80,000 a year. Share your stories to advance drug-pricing transparency.

Federal Advocacy
·
2 Min Read

AMA: Trump administration requiring pricing information in TV drug ads

The Trump Administration has taken a step in the right direction requiring pricing information in television advertising of prescription drugs.

Press Releases
·
5 Min Read

AMA, NCMS, Manatt: Study of NC reversing opioid epidemic

A new report today by the AMA, North Carolina Medical Soc, and Manatt Health shows North Carolina is adopting strategies to combat the opioid epidemic.

Press Releases
·
5 Min Read

AMA, MSMA, Manatt: Study on MS reversing opioid epidemic

A new report today by the AMA, Mississippi State Medical Assn (MSMA), and Manatt Health shows Mississippi is adopting strategies to combat the opioid epidemic.

Press Releases
·
3 Min Read

Iowa removes barriers to treatment of opioid use disorder

Physicians congratulating the Iowa Legislature and Gov. Reynolds for passing a law that results in more residents receiving treatment for opioid use disorder.

Press Releases
Physician writing on a prescription tablet
·
2 Min Read

How the CDC’s opioid prescribing guidance went astray

Payers, regulators and others have turned clinical advice into hard-and-fast rules that can harm patients.

Behavioral Health
1 Min Read

The truth behind drug prescription pricing

Spending on prescription drugs is on the rise in the United States, but lack of oversight on drug pricing offers no answers for price fluctuations.

Federal Advocacy
·
3 Min Read

AMA urges participation in Prescription Drug Take Back Day

Doctors are urging their patients to participate in National Prescription Drug Take Back Day by taking unused and expired medicine to drop-off sites.

Press Releases
·
2 Min Read

AMA welcomes CDC’s revised view on opioids guidelines

The AMA continues to urge informed prescribing to reduce opioid-related harm and appreciates the CDC recognizes that patients require individualized care.

Press Releases